136
Participants
Start Date
July 31, 2023
Primary Completion Date
February 28, 2025
Study Completion Date
October 9, 2025
Povorcitinib
oral; tablet
Placebo
oral; tablet
Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin
Dermdox Center For Dermatology, Sugarloaf
Mensingderma Research Gmbh, Hamburg
Universitaetsklinikum Schleswig-Holstein - Campus Kiel, Kiel
Allergy and Asthma Center of Charleston, Charleston
Clinical Research Center of Alabama, Birmingham
Cahaba Dermatology, Birmingham
Optimed Research Ltd, Columbus
Revival Research Institute, Llc Troy, Troy
David Fivenson, Md, Dermatology, Pllc, Ann Arbor
Klifos - Klinische Forschung Osnabruck, Osnabrück
Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii, Mainz
Universitatsklinikum Frankfurt, Frankfurt
Midwest Allergy Sinus Asthma, Sc, Normal
The Clinical Research Center Crc, Llc, St Louis
Delricht Research, New Orleans
Universitats-Hautklink Tubingen, Tübingen
Arkansas Research Trials, North Little Rock
Little Rock Allergy Asthma, Pa Clinical Research Center Lraac, Little Rock
Central Sooner Research, Oklahoma City
Vital Prospects Clinical Research Institute, Pc Vpcri, Tulsa
Rainey and Finklea Dermatology, San Antonio
Treasure Valley Medical Research, Boise
Foothills Research Center, Scottsdale
Newport Native Md, Newport Beach
First Oc Dermatology, Fountain Valley
Antelope Valley Clinical Trials Lancaster Office, Palmdale
Allergy and Asthma Consultants, Pc, Redwood City
Bellingham Asthma, Allergy Immunology Clinic, Bellingham
Universitaetsklinikum Carl Gustav Carus Tu Dresden, Dresden
Universitatsklinikum Leipzig Aor, Leipzig
Specderm Poznanska, Bialystok
Centrum Medyczne Pratia Katowice I, Katowice
Centrum Alergologii Sp Z.O.O, Lublin
University Clinical Hospital, Opole
Solumed Centrum Medyczne, Poznan
Specjalistyczny Nzoz Alergologia Plus, Poznan
DC-MED, Swidnica
Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych Administracji, Warsaw
Etg Warszawa, Warsaw
Klinika Ambroziak, Warsaw
Melita Medical Sp. Z O. O., Wroclaw
Lead Sponsor
Incyte Corporation
INDUSTRY